Development Collaboration and Exclusive License Agreement Sample Contracts

DEVELOPMENT COLLABORATION AND exclusive LICENSE AGREEMENT

Development Collaboration and Exclusive License Agreement • November 13th, 2018 • Molecular Templates, Inc. • Pharmaceutical preparations • Massachusetts

• Contract Type
  Development Collaboration and Exclusive License Agreement
• Filed
  November 13th, 2018
• Company
  Molecular Templates, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Massachusetts

This Development Collaboration and Exclusive License Agreement (this “Agreement”) is entered into as of September 18, 2018 (the “Effective Date”) by and between MOLECULAR TEMPLATES, INC., a Delaware corporation, having its principal place of business at 9301 Amberglen Boulevard, Suite 100, Austin, TX 78729 (“MTEM”) and MILLENNIUM PHARMACEUTICALS, INC., a Delaware corporation, a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, having its principal place of business at 40 Landsdowne Street, Cambridge, MA 02139 (“Takeda”). MTEM and Takeda may sometimes individually be referred to hereafter as a “Party” or collectively as the “Parties.”